Evidence map›Paper›PMID 42293490›Full record

ArticleRadiology case reports2026

Orbital lymphangioma mimicking cellulitis: Diagnostic contribution of MRI and successful management with bleomycin sclerotherapy.

Mohamed Bouallou, Issam Berrajaa, M'barek Ben Youssef, Achraf Amine Sbai, Drissia Benfadil, Azeddine Lachkar

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed BouallouDepartment of Otorhinolaryngology, Mohammed VI University Hospital, Oujda, 60000, Morocco.
Issam BerrajaaDepartment of Otorhinolaryngology, Mohammed VI University Hospital, Oujda, 60000, Morocco.
M'barek Ben YoussefDepartment of Otorhinolaryngology, Mohammed VI University Hospital, Oujda, 60000, Morocco.
Achraf Amine SbaiDepartment of Otorhinolaryngology, Mohammed VI University Hospital, Oujda, 60000, Morocco.
Drissia BenfadilDepartment of Otorhinolaryngology, Mohammed VI University Hospital, Oujda, 60000, Morocco.
Azeddine LachkarDepartment of Otorhinolaryngology, Mohammed VI University Hospital, Oujda, 60000, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orbital lymphangioma is a rare benign low-flow venous-lymphatic malformation that typically presents with slowly progressive proptosis in children. Acute inflammatory presentations mimicking orbital cellulitis are uncommon and may lead to diagnostic delay. We report the case of an 11-year-old girl presenting with acute left-sided facial swelling and proptosis following an upper respiratory tract infection. Initial management for presumed orbital cellulitis with intravenous antibiotic therapy was unsuccessful. Contrast-enhanced CT showed diffuse soft tissue infiltration without abscess formation, while MRI revealed a multiloculated cystic lesion with hemorrhagic components involving both intra- and extraconal spaces, consistent with orbital lymphangioma. The patient underwent 3 sessions of bleomycin-based sclerotherapy at 1-month intervals, with good tolerance and no complications. Progressive clinical improvement was observed, with complete resolution of proptosis and chemosis at 5 months and no recurrence at 1-year follow-up. This case highlights the key role of MRI in differentiating orbital lymphangioma from infectious processes and supports sclerotherapy as an effective minimally invasive treatment option.

Indexed as

BleomycinMagnetic resonance imagingOrbital cellulitisOrbital lymphangiomaSclerotherapy

Identifiers

PMID42293490
PMCPMC13262156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.